Novartis (NVS)
(Delayed Data from NYSE)
$99.60 USD
+0.53 (0.53%)
Updated May 8, 2024 04:00 PM ET
After-Market: $99.62 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Bottom 40% (151 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.45 | 2.10 | 9.99 |
Current Quarter Estimate | 1.85 | 37.64 | 57.00 |
Year Ago Quarter Estimate | 1.83 | 11.39 | 52.54 |
Next Quarter Estimate | 1.90 | 34.85 | 61.00 |
Next Year Estimate | 8.14 | 178.47 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 5.22 | 5.10 | 15.67 |
Next Year | 12.12 | 14.30 | 9.31 |
Last 5 Years | 6.40 | 3.00 | 8.10 |
Next 5 Years | 8.60 | 12.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 14.36 | 15.53 |
Price/Book (MRQ) | 5.09 | 5.58 |
Price/Cash Flow (MRFY) | 8.92 | 9.98 |
Dividend Yield | 2.45% | 2.51% |
Net Profit Margin (TTM) | 31.33% | 13.30% |
Return on Equity (TTM) | 32.15% | 32.15% |
Debt to Equity (MRQ) | 0.43 | 30.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.